Detalles de la búsqueda
1.
Clinical trials and drug cost savings for Italian health service.
BMC Health Serv Res
; 20(1): 1089, 2020 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33243262
2.
Electrochemotherapy efficacy evaluation for treatment of locally advanced stage III cutaneous squamous cell carcinoma: a 22-cases retrospective analysis.
J Transl Med
; 15(1): 82, 2017 04 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-28441954
3.
Complete response to nivolumab monotherapy in a treatment-naive, BRAF wild-type patient with advanced mucosal melanoma and elevated lactate dehydrogenase: a case report from a phase III trial.
Cancer Immunol Immunother
; 65(11): 1395-1400, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27604993
4.
Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report.
BMC Dermatol
; 14: 15, 2014 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-25270710
5.
Do BRAF inhibitors select for populations with different disease progression kinetics?
J Transl Med
; 11: 61, 2013 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-23497384
6.
Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma.
J Transl Med
; 11: 38, 2013 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-23402397
7.
Lean oncology: a new model for oncologists.
J Transl Med
; 10: 74, 2012 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-22533796
8.
Pancreatic Cancer: Beyond Brca Mutations.
J Pers Med
; 12(12)2022 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36556296
9.
The Ratio of GrzB+ - FoxP3+ over CD3+ T Cells as a Potential Predictor of Response to Nivolumab in Patients with Metastatic Melanoma.
Cancers (Basel)
; 13(10)2021 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34066146
10.
Clinical Categorization Algorithm (CLICAL) and Machine Learning Approach (SRF-CLICAL) to Predict Clinical Benefit to Immunotherapy in Metastatic Melanoma Patients: Real-World Evidence from the Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
Cancers (Basel)
; 13(16)2021 Aug 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34439318
11.
Clinical Outcome Prediction in COVID-19 Patients by Lymphocyte Subsets Analysis and Monocytes' iTNF-α Expression.
Biology (Basel)
; 10(8)2021 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34439967
12.
Nivolumab for the treatment of small cell lung cancer.
Expert Rev Respir Med
; 14(1): 5-13, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31622114
13.
Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy.
J Immunother Cancer
; 8(2)2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32784217
14.
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients.
Crit Rev Oncol Hematol
; 156: 103118, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33038627
15.
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists.
J Immunother Cancer
; 8(2)2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33060148
16.
Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.
J Immunother Cancer
; 6(1): 74, 2018 07 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30012216
17.
Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenib.
Oncotarget
; 9(15): 12408-12417, 2018 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-29552321
18.
Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma.
Oncoimmunology
; 6(3): e1283462, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28405510
19.
Single versus combination immunotherapy drug treatment in melanoma.
Expert Opin Biol Ther
; 16(4): 433-41, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26642234
20.
Novel mechanisms and therapeutic approaches in melanoma: targeting the MAPK pathway.
Discov Med
; 19(107): 455-61, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26175403